GL1X · GenesisL1 explorer

MolNFT v1 · #121827 · protein

Structure of F285S, a cancer-associated mutation of the oncogenic phosphatase SHP2

5I6V · Tyrosine-protein phosphatase non-receptor type 11: “Structure of F285S, a cancer-associated mutation of the oncogenic phosphatase SHP2”. X-ray diffraction, 11 pockets (best druggability 0.68). MolNFT v1 #121827 on GenesisL1: 3D…

PDB
5I6V
Type
protein
Length
984 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein phosphatase non-receptor type 11
EC
3.1.3.48
UniProt
Q06124
Pockets
11 · best druggability 0.68

Structure

x-ray diffraction · 2 distinct chains · 30% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein48830% helix, 27% strandQ06124
BTyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein49630% helix, 26% strandQ06124

Ligands and binding sites

  • GOL · Glycerol · additive · 2 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18380.680.7493GOL
22520.580.7928empty
32700.570.7828empty
42660.510.7438empty
51180.410.7619empty

Interfaces

1 interface between chains.

  • A–B · 673 Ų buried · 11 hydrogen bonds · protein-protein

Compared structures

  • 5I6V · Structure of F285S, a Cancer-Associated Mutation of the Oncogenic Phosphatase SHP2 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.